Korea Biomedical Review | ‘Training future workforce to develop next-gen mRNA therapeutics requires close collab’
2023. 7. 03, 코리아 바이오메디칼 리뷰
With Covid-19 vaccines ushering in a new era for mRNA therapeutics, there has been a lot of buzz surrounding new mRNA therapies in the field of protein replacement therapies, autoimmune diseases, cancer vaccines, and infectious diseases.